Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
CARD Signaling Adaptor Proteins | 8 | 2019 | 156 | 2.660 |
Why?
|
Asthma | 21 | 2023 | 6011 | 1.410 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2022 | 451 | 1.380 |
Why?
|
Allergens | 14 | 2023 | 1320 | 1.220 |
Why?
|
Lung | 30 | 2023 | 9856 | 1.170 |
Why?
|
Pulmonary Fibrosis | 6 | 2024 | 530 | 1.060 |
Why?
|
Respiratory Hypersensitivity | 6 | 2019 | 274 | 0.890 |
Why?
|
Hypersensitivity | 5 | 2023 | 1102 | 0.880 |
Why?
|
Capillary Permeability | 3 | 2022 | 798 | 0.800 |
Why?
|
Th2 Cells | 7 | 2016 | 1061 | 0.800 |
Why?
|
Ovalbumin | 11 | 2015 | 719 | 0.790 |
Why?
|
Alternaria | 2 | 2018 | 44 | 0.790 |
Why?
|
Hypertension, Pulmonary | 5 | 2012 | 1537 | 0.720 |
Why?
|
Chemotaxis, Leukocyte | 8 | 2011 | 675 | 0.720 |
Why?
|
Disintegrins | 1 | 2018 | 25 | 0.670 |
Why?
|
Receptors, Leukotriene B4 | 4 | 2005 | 94 | 0.640 |
Why?
|
Orthomyxoviridae Infections | 3 | 2024 | 248 | 0.620 |
Why?
|
Chemokines, CXC | 5 | 2008 | 422 | 0.580 |
Why?
|
Eosinophils | 2 | 2011 | 955 | 0.570 |
Why?
|
Lysophospholipids | 3 | 2022 | 331 | 0.550 |
Why?
|
Adiponectin | 6 | 2021 | 1100 | 0.550 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2021 | 4479 | 0.550 |
Why?
|
Exchange Transfusion, Whole Blood | 2 | 2005 | 56 | 0.530 |
Why?
|
Lung Diseases | 5 | 2020 | 1886 | 0.530 |
Why?
|
Airway Remodeling | 2 | 2019 | 132 | 0.500 |
Why?
|
Bronchiolitis Obliterans | 2 | 2006 | 192 | 0.490 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2916 | 0.480 |
Why?
|
Pulmonary Eosinophilia | 3 | 2011 | 82 | 0.480 |
Why?
|
Pulmonary Artery | 3 | 2011 | 1912 | 0.470 |
Why?
|
Pneumonia | 4 | 2022 | 2133 | 0.460 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2021 | 4386 | 0.430 |
Why?
|
Respiratory System | 2 | 2016 | 557 | 0.430 |
Why?
|
Epithelial Cells | 4 | 2018 | 3690 | 0.420 |
Why?
|
Disease Models, Animal | 19 | 2018 | 18029 | 0.420 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3462 | 0.420 |
Why?
|
Guanylate Cyclase | 1 | 2013 | 201 | 0.410 |
Why?
|
Mice | 42 | 2024 | 81183 | 0.410 |
Why?
|
Receptors, Chemokine | 6 | 2008 | 669 | 0.410 |
Why?
|
Respiration, Artificial | 4 | 2020 | 2569 | 0.390 |
Why?
|
Bleomycin | 3 | 2022 | 512 | 0.390 |
Why?
|
Mice, Transgenic | 14 | 2022 | 9734 | 0.390 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2020 | 2988 | 0.380 |
Why?
|
Respiratory Mucosa | 3 | 2021 | 427 | 0.380 |
Why?
|
T-Lymphocytes | 6 | 2013 | 10180 | 0.360 |
Why?
|
Mice, Knockout | 18 | 2018 | 14557 | 0.350 |
Why?
|
Endothelial Cells | 2 | 2022 | 3479 | 0.350 |
Why?
|
Inflammation | 15 | 2023 | 10638 | 0.350 |
Why?
|
STAT6 Transcription Factor | 2 | 2009 | 199 | 0.340 |
Why?
|
Animals | 50 | 2024 | 168757 | 0.340 |
Why?
|
Mice, Inbred C57BL | 19 | 2022 | 21827 | 0.340 |
Why?
|
Bronchial Hyperreactivity | 4 | 2010 | 319 | 0.330 |
Why?
|
Receptors, Virus | 1 | 2012 | 648 | 0.330 |
Why?
|
Scapula | 1 | 2010 | 164 | 0.330 |
Why?
|
Receptors, CXCR3 | 7 | 2021 | 237 | 0.330 |
Why?
|
Bronchoalveolar Lavage | 4 | 2016 | 120 | 0.330 |
Why?
|
Chemokine CCL20 | 1 | 2008 | 64 | 0.320 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 171 | 0.320 |
Why?
|
Chemokines | 5 | 2013 | 970 | 0.310 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3047 | 0.310 |
Why?
|
Tomography, Optical Coherence | 5 | 2022 | 2657 | 0.310 |
Why?
|
Receptors, Purinergic P2 | 2 | 2005 | 153 | 0.300 |
Why?
|
Anemia, Sickle Cell | 2 | 2005 | 1018 | 0.290 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2010 | 1504 | 0.290 |
Why?
|
Up-Regulation | 4 | 2012 | 4217 | 0.290 |
Why?
|
Chemotaxis | 2 | 2021 | 607 | 0.290 |
Why?
|
Respiratory Mechanics | 3 | 2020 | 686 | 0.290 |
Why?
|
Bone Diseases | 1 | 2010 | 416 | 0.280 |
Why?
|
Cells, Cultured | 11 | 2018 | 19229 | 0.280 |
Why?
|
Bronchoalveolar Lavage Fluid | 8 | 2021 | 768 | 0.260 |
Why?
|
Fibroblasts | 3 | 2022 | 4161 | 0.260 |
Why?
|
Antigen-Antibody Reactions | 1 | 2005 | 363 | 0.260 |
Why?
|
Lung Transplantation | 3 | 2013 | 1153 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3255 | 0.250 |
Why?
|
T-Lymphocyte Subsets | 4 | 2009 | 1838 | 0.250 |
Why?
|
Bronchial Diseases | 1 | 2005 | 151 | 0.250 |
Why?
|
Smoking | 4 | 2021 | 8987 | 0.240 |
Why?
|
Bronchoscopy | 3 | 2021 | 862 | 0.240 |
Why?
|
Dendritic Cells | 1 | 2015 | 2725 | 0.240 |
Why?
|
Myeloid Cells | 1 | 2009 | 810 | 0.230 |
Why?
|
Cytokines | 8 | 2016 | 7322 | 0.230 |
Why?
|
Granulocytes | 1 | 2005 | 548 | 0.230 |
Why?
|
Trachea | 2 | 2006 | 1076 | 0.220 |
Why?
|
Ventilator Weaning | 2 | 2021 | 148 | 0.220 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2016 | 0.220 |
Why?
|
Inflammation Mediators | 3 | 2021 | 1889 | 0.210 |
Why?
|
Coronavirus Infections | 4 | 2021 | 3133 | 0.210 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1199 | 0.210 |
Why?
|
Pulmonary Gas Exchange | 3 | 2020 | 382 | 0.210 |
Why?
|
Macrophages, Alveolar | 3 | 2021 | 407 | 0.210 |
Why?
|
HIV Infections | 6 | 2021 | 16718 | 0.200 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2008 | 1157 | 0.200 |
Why?
|
Positive-Pressure Respiration | 3 | 2020 | 633 | 0.200 |
Why?
|
Chemokine CXCL10 | 5 | 2021 | 304 | 0.190 |
Why?
|
Chemokine CCL24 | 2 | 2011 | 8 | 0.190 |
Why?
|
rho-Associated Kinases | 2 | 2023 | 279 | 0.190 |
Why?
|
Lung Diseases, Obstructive | 2 | 1998 | 316 | 0.190 |
Why?
|
Graft Rejection | 3 | 2013 | 4397 | 0.190 |
Why?
|
Viral Tropism | 1 | 2021 | 101 | 0.190 |
Why?
|
Acyl Coenzyme A | 1 | 2020 | 55 | 0.180 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 61 | 0.180 |
Why?
|
Respiratory Function Tests | 3 | 2021 | 1616 | 0.180 |
Why?
|
Mevalonic Acid | 1 | 2020 | 42 | 0.180 |
Why?
|
Influenza, Human | 2 | 2021 | 1479 | 0.170 |
Why?
|
Sphingosine | 1 | 2022 | 307 | 0.170 |
Why?
|
HIV-1 | 3 | 2021 | 6939 | 0.170 |
Why?
|
Humans | 61 | 2024 | 744343 | 0.170 |
Why?
|
Signal Transduction | 7 | 2021 | 23403 | 0.170 |
Why?
|
Adoptive Transfer | 4 | 2011 | 844 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2013 | 2540 | 0.170 |
Why?
|
Metalloproteases | 1 | 2018 | 62 | 0.160 |
Why?
|
Mice, Inbred BALB C | 6 | 2009 | 6386 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3240 | 0.160 |
Why?
|
Gene Deletion | 2 | 2022 | 2751 | 0.160 |
Why?
|
Bronchi | 3 | 2021 | 840 | 0.150 |
Why?
|
Tobacco Smoke Pollution | 1 | 2023 | 816 | 0.150 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 739 | 0.150 |
Why?
|
Interleukin-1 | 2 | 2012 | 1263 | 0.150 |
Why?
|
Simvastatin | 1 | 2020 | 360 | 0.150 |
Why?
|
Pyroglyphidae | 2 | 2015 | 88 | 0.150 |
Why?
|
Lactates | 1 | 1998 | 432 | 0.150 |
Why?
|
Immunomodulation | 1 | 2020 | 541 | 0.140 |
Why?
|
NF-kappa B | 4 | 2015 | 2499 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
Chemokine CXCL9 | 3 | 2006 | 132 | 0.140 |
Why?
|
Exercise Tolerance | 1 | 2021 | 770 | 0.140 |
Why?
|
Blood Coagulation | 1 | 2022 | 1127 | 0.130 |
Why?
|
Obesity | 3 | 2021 | 12745 | 0.130 |
Why?
|
Muscle, Smooth | 2 | 2016 | 934 | 0.130 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1877 | 0.130 |
Why?
|
Cytoplasm | 1 | 2020 | 1539 | 0.130 |
Why?
|
Mycobacterium tuberculosis | 2 | 2023 | 1832 | 0.130 |
Why?
|
Antioxidants | 1 | 2023 | 1663 | 0.130 |
Why?
|
Exercise Test | 3 | 2021 | 2074 | 0.130 |
Why?
|
STAT1 Transcription Factor | 2 | 2006 | 320 | 0.130 |
Why?
|
Bone Marrow | 1 | 2005 | 2948 | 0.120 |
Why?
|
Dyspnea | 2 | 2021 | 1303 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1676 | 0.120 |
Why?
|
Immunotherapy | 2 | 2021 | 4445 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 828 | 0.120 |
Why?
|
Mucus | 4 | 2016 | 321 | 0.120 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2019 | 570 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 2007 | 0.120 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 720 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
Lymphocyte Activation | 7 | 2011 | 5524 | 0.120 |
Why?
|
Cell Movement | 6 | 2013 | 5217 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2021 | 975 | 0.120 |
Why?
|
Cell Proliferation | 6 | 2013 | 10481 | 0.120 |
Why?
|
Receptors, CCR5 | 2 | 2021 | 497 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1072 | 0.110 |
Why?
|
Male | 30 | 2021 | 350118 | 0.110 |
Why?
|
Receptors, CCR4 | 2 | 2013 | 81 | 0.110 |
Why?
|
Interferon-gamma | 5 | 2019 | 3206 | 0.110 |
Why?
|
Cell Dedifferentiation | 1 | 2013 | 135 | 0.110 |
Why?
|
Multiprotein Complexes | 1 | 2019 | 1119 | 0.110 |
Why?
|
Immunophenotyping | 3 | 2020 | 1880 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2023 | 2987 | 0.110 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 810 | 0.110 |
Why?
|
Pulmonary Embolism | 1 | 2005 | 2376 | 0.110 |
Why?
|
Lymphocyte Subsets | 1 | 2013 | 315 | 0.100 |
Why?
|
Positron-Emission Tomography | 3 | 2020 | 6234 | 0.100 |
Why?
|
Hyperplasia | 2 | 2021 | 1185 | 0.100 |
Why?
|
Receptors, OX40 | 1 | 2011 | 43 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2013 | 809 | 0.100 |
Why?
|
Pandemics | 3 | 2020 | 8388 | 0.100 |
Why?
|
Chemokine CCL11 | 1 | 2011 | 129 | 0.100 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2011 | 116 | 0.100 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2011 | 42 | 0.100 |
Why?
|
Mitogens | 1 | 2011 | 232 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2183 | 0.100 |
Why?
|
Neutrophil Infiltration | 2 | 2012 | 390 | 0.100 |
Why?
|
Immunoglobulin E | 3 | 2006 | 1463 | 0.100 |
Why?
|
Cell Extracts | 1 | 2011 | 138 | 0.100 |
Why?
|
Microscopy | 1 | 2016 | 903 | 0.100 |
Why?
|
Phosphoproteins | 1 | 2020 | 2440 | 0.100 |
Why?
|
Tuberculosis | 1 | 2023 | 1912 | 0.100 |
Why?
|
Interleukin-5 | 1 | 2011 | 273 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2020 | 2969 | 0.100 |
Why?
|
Fibrosis | 3 | 2023 | 2029 | 0.090 |
Why?
|
Lung Compliance | 2 | 2009 | 195 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2015 | 2958 | 0.090 |
Why?
|
Cats | 1 | 2011 | 998 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 713 | 0.090 |
Why?
|
Cough | 2 | 2011 | 555 | 0.090 |
Why?
|
Female | 30 | 2021 | 380194 | 0.090 |
Why?
|
Phenotype | 3 | 2023 | 16365 | 0.090 |
Why?
|
Molecular Probe Techniques | 1 | 2010 | 119 | 0.090 |
Why?
|
Airway Resistance | 2 | 2009 | 404 | 0.090 |
Why?
|
Tomography, Optical | 1 | 2010 | 126 | 0.090 |
Why?
|
Chemokine CCL22 | 1 | 2009 | 26 | 0.090 |
Why?
|
Chemokine CCL17 | 1 | 2009 | 23 | 0.090 |
Why?
|
Receptors, CCR8 | 1 | 2008 | 27 | 0.080 |
Why?
|
Cell Migration Inhibition | 2 | 2006 | 96 | 0.080 |
Why?
|
Integrases | 1 | 2011 | 533 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2203 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 617 | 0.080 |
Why?
|
Myofibroblasts | 2 | 2023 | 222 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 2025 | 0.080 |
Why?
|
Th17 Cells | 1 | 2015 | 766 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2012 | 1369 | 0.080 |
Why?
|
Hypoventilation | 1 | 2008 | 38 | 0.080 |
Why?
|
Lung Injury | 1 | 2013 | 436 | 0.080 |
Why?
|
Cell Polarity | 1 | 2011 | 645 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2012 | 1526 | 0.080 |
Why?
|
Antibodies | 2 | 2016 | 2460 | 0.080 |
Why?
|
Cell Differentiation | 4 | 2023 | 11483 | 0.070 |
Why?
|
Neoplasms | 3 | 2021 | 21683 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1856 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2011 | 687 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2016 | 5974 | 0.070 |
Why?
|
Biological Transport | 1 | 2011 | 2118 | 0.070 |
Why?
|
Monocytes | 2 | 2023 | 2596 | 0.070 |
Why?
|
Chemokine CXCL11 | 2 | 2006 | 42 | 0.070 |
Why?
|
Macrophages | 3 | 2023 | 5655 | 0.070 |
Why?
|
Paralysis | 1 | 2008 | 247 | 0.070 |
Why?
|
Radiography | 2 | 2010 | 7023 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2008 | 3474 | 0.070 |
Why?
|
Leukotriene B4 | 2 | 2005 | 294 | 0.070 |
Why?
|
Tidal Volume | 1 | 2008 | 490 | 0.070 |
Why?
|
Transplantation Tolerance | 1 | 2011 | 617 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2455 | 0.070 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2007 | 880 | 0.070 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 316 | 0.070 |
Why?
|
Adipocytes | 1 | 2012 | 1184 | 0.060 |
Why?
|
Models, Immunological | 1 | 2008 | 527 | 0.060 |
Why?
|
Adult | 15 | 2023 | 214055 | 0.060 |
Why?
|
Heart Diseases | 1 | 1998 | 2788 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 3002 | 0.060 |
Why?
|
Exercise | 2 | 1998 | 5615 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2011 | 1348 | 0.060 |
Why?
|
Reference Standards | 2 | 2020 | 1025 | 0.060 |
Why?
|
Th1 Cells | 2 | 2008 | 1057 | 0.060 |
Why?
|
Epinephrine | 1 | 2008 | 792 | 0.060 |
Why?
|
Homeostasis | 1 | 2015 | 3340 | 0.060 |
Why?
|
Lymphocyte Count | 1 | 2006 | 793 | 0.060 |
Why?
|
Infarction | 1 | 2005 | 244 | 0.060 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 645 | 0.060 |
Why?
|
Conscious Sedation | 1 | 2008 | 528 | 0.060 |
Why?
|
Phosphorylation | 2 | 2012 | 8436 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2008 | 1730 | 0.060 |
Why?
|
Bone Marrow Diseases | 1 | 2005 | 231 | 0.060 |
Why?
|
Paroxetine | 1 | 2024 | 182 | 0.060 |
Why?
|
Acute Disease | 2 | 2011 | 7149 | 0.060 |
Why?
|
Middle Aged | 15 | 2021 | 213383 | 0.060 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 973 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12208 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13102 | 0.050 |
Why?
|
Serum Response Factor | 1 | 2023 | 81 | 0.050 |
Why?
|
Influenza A virus | 2 | 2021 | 456 | 0.050 |
Why?
|
Pain | 2 | 2010 | 4986 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2699 | 0.050 |
Why?
|
Nausea | 1 | 2005 | 673 | 0.050 |
Why?
|
Lymphocytes | 2 | 2008 | 2617 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2009 | 1782 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 425 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2011 | 5078 | 0.050 |
Why?
|
Protein Kinases | 1 | 2008 | 1640 | 0.050 |
Why?
|
Respiration | 1 | 2008 | 1653 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2021 | 3200 | 0.050 |
Why?
|
Endothelium | 1 | 2024 | 778 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2021 | 209 | 0.050 |
Why?
|
Back Pain | 1 | 2005 | 545 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2023 | 595 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12959 | 0.050 |
Why?
|
Cell Culture Techniques | 2 | 2021 | 1678 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2765 | 0.050 |
Why?
|
Administration, Inhalation | 2 | 2020 | 1105 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20129 | 0.050 |
Why?
|
Stem Cells | 1 | 2013 | 3567 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2005 | 1850 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2012 | 3279 | 0.050 |
Why?
|
Mice, Inbred C3H | 2 | 2012 | 964 | 0.040 |
Why?
|
Leg | 1 | 2005 | 1116 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2915 | 0.040 |
Why?
|
Antigens | 3 | 2013 | 1466 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 56430 | 0.040 |
Why?
|
Intubation, Intratracheal | 3 | 2020 | 1364 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 675 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2015 | 12072 | 0.040 |
Why?
|
RNA Interference | 1 | 2008 | 2889 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1026 | 0.040 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2005 | 570 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.040 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2000 | 197 | 0.040 |
Why?
|
Prone Position | 1 | 2020 | 194 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2000 | 215 | 0.040 |
Why?
|
Bronchial Provocation Tests | 1 | 2019 | 227 | 0.040 |
Why?
|
Ligands | 1 | 2006 | 3282 | 0.040 |
Why?
|
Coronavirus | 1 | 2021 | 158 | 0.040 |
Why?
|
Ventriculography, First-Pass | 1 | 1998 | 20 | 0.040 |
Why?
|
Equipment Design | 2 | 2021 | 3582 | 0.040 |
Why?
|
Base Sequence | 2 | 2010 | 12797 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2010 | 2071 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 2872 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 257 | 0.040 |
Why?
|
Neutrophils | 2 | 2013 | 3719 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 673 | 0.040 |
Why?
|
Physical Exertion | 1 | 2021 | 695 | 0.040 |
Why?
|
Streptococcus pyogenes | 1 | 2000 | 289 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 324 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7722 | 0.040 |
Why?
|
Nanotechnology | 1 | 2023 | 710 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4034 | 0.040 |
Why?
|
Birefringence | 1 | 2016 | 56 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 642 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1999 | 707 | 0.040 |
Why?
|
Collagen | 1 | 2005 | 2689 | 0.040 |
Why?
|
Chronic Disease | 1 | 2011 | 9146 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 2016 | 142 | 0.040 |
Why?
|
Receptors, CCR6 | 2 | 2007 | 81 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2005 | 4560 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2006 | 4456 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2018 | 328 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 1998 | 292 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2020 | 593 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6256 | 0.030 |
Why?
|
Harmine | 1 | 2015 | 11 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2020 | 977 | 0.030 |
Why?
|
Insulin | 1 | 2010 | 6580 | 0.030 |
Why?
|
Streptococcal Infections | 1 | 2000 | 638 | 0.030 |
Why?
|
Cardiac Output | 1 | 1998 | 854 | 0.030 |
Why?
|
Virus Replication | 1 | 2023 | 2534 | 0.030 |
Why?
|
Cell Line | 3 | 2021 | 15997 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1155 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6364 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 437 | 0.030 |
Why?
|
Liver | 1 | 2010 | 7474 | 0.030 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1092 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2020 | 804 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2023 | 2703 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 961 | 0.030 |
Why?
|
Quality Control | 1 | 2016 | 841 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 21746 | 0.030 |
Why?
|
Hemodynamics | 2 | 2021 | 4199 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 2019 | 846 | 0.030 |
Why?
|
Receptors, CCR7 | 1 | 2013 | 108 | 0.030 |
Why?
|
Leptin | 1 | 2021 | 1599 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2007 | 1147 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3299 | 0.030 |
Why?
|
Cartilage | 1 | 2016 | 818 | 0.030 |
Why?
|
Gene Expression | 3 | 2013 | 7799 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2019 | 2375 | 0.030 |
Why?
|
Interleukin-1alpha | 1 | 2012 | 84 | 0.030 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.030 |
Why?
|
Leukocytes | 1 | 2020 | 2043 | 0.030 |
Why?
|
Doxycycline | 1 | 2013 | 326 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 1998 | 1869 | 0.030 |
Why?
|
Dogs | 1 | 2016 | 3912 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2016 | 1240 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2000 | 2132 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1349 | 0.020 |
Why?
|
Risk Factors | 2 | 2021 | 72290 | 0.020 |
Why?
|
Hamartoma | 1 | 2013 | 238 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1998 | 1738 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2013 | 252 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2010 | 248 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2019 | 2258 | 0.020 |
Why?
|
Piperazines | 1 | 2000 | 2488 | 0.020 |
Why?
|
Mice, Obese | 1 | 2010 | 424 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
Rabbits | 2 | 2010 | 4894 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1836 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1354 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2518 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
Tamoxifen | 1 | 2013 | 981 | 0.020 |
Why?
|
Patient Selection | 1 | 2021 | 4215 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2013 | 506 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40075 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 503 | 0.020 |
Why?
|
Immunization | 1 | 2013 | 1256 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9849 | 0.020 |
Why?
|
Computer-Aided Design | 1 | 2010 | 298 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8642 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2013 | 1200 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 868 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2021 | 3864 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5317 | 0.020 |
Why?
|
Critical Care | 1 | 2000 | 2647 | 0.020 |
Why?
|
Egg Proteins | 1 | 2006 | 58 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2010 | 611 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 342 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 972 | 0.020 |
Why?
|
Chemokine CXCL6 | 1 | 2006 | 13 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2013 | 1904 | 0.020 |
Why?
|
Spleen | 1 | 2012 | 2362 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2010 | 5097 | 0.020 |
Why?
|
Receptors, Interleukin-8A | 1 | 2005 | 44 | 0.020 |
Why?
|
Receptors, Scavenger | 1 | 2006 | 121 | 0.020 |
Why?
|
Sepsis | 1 | 2000 | 2593 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1878 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57776 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2892 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2006 | 898 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1524 | 0.020 |
Why?
|
Algorithms | 1 | 2005 | 13881 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2010 | 4320 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12261 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15519 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5882 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4042 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 2002 | 156 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2008 | 899 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 2002 | 178 | 0.010 |
Why?
|
Autophagy | 1 | 2010 | 1300 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1998 | 15076 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9727 | 0.010 |
Why?
|
Nebulizers and Vaporizers | 1 | 2002 | 139 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5751 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2006 | 1284 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2000 | 34 | 0.010 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2000 | 56 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2010 | 13033 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2002 | 608 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2005 | 1041 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6622 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8480 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2006 | 3144 | 0.010 |
Why?
|
Aerosols | 1 | 2002 | 625 | 0.010 |
Why?
|
Positive-Pressure Respiration, Intrinsic | 1 | 1999 | 9 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 2133 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13815 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 77449 | 0.010 |
Why?
|
Integrins | 1 | 2002 | 846 | 0.010 |
Why?
|
Prognosis | 1 | 1998 | 29063 | 0.010 |
Why?
|
Sulfones | 1 | 2000 | 437 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1999 | 1581 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 18111 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1998 | 383 | 0.010 |
Why?
|
Tunica Intima | 1 | 1999 | 464 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2000 | 478 | 0.010 |
Why?
|
Acidosis, Lactic | 1 | 1998 | 142 | 0.010 |
Why?
|
Receptors, LDL | 1 | 1999 | 475 | 0.010 |
Why?
|
Purines | 1 | 2000 | 594 | 0.010 |
Why?
|
Pulmonary Ventilation | 1 | 1999 | 373 | 0.010 |
Why?
|
Drug Synergism | 1 | 2000 | 1792 | 0.010 |
Why?
|
Child | 1 | 2023 | 77709 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14722 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12788 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 1999 | 1438 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 1999 | 1970 | 0.010 |
Why?
|
Esophagus | 1 | 1999 | 1019 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1999 | 1151 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1999 | 2216 | 0.010 |
Why?
|
Aorta | 1 | 1999 | 2061 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9438 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16689 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 85781 | 0.000 |
Why?
|